| Axon ID |
Name |
Description |
From price |
|
1136
|
SU 6656
|
SRC kinase inhibitor |
€120.00 |
|
1137
|
PD180970
|
Bcr-Abl tyrosine kinase inhibitor (p210 specific) |
€120.00 |
|
1394
|
Imatinib mesylate
|
Bcr-Abl, c-KIT and PDGFR kinase inhibitor |
€60.00 |
|
1396
|
Nilotinib
|
BCR-ABL inhibitor |
€50.00 |
|
1407
|
SKI 606
|
Bcr-Abl and Src tyrosine kinase inhibitor |
€75.00 |
|
1456
|
AZD0530 difumarate
|
Inhibitor of SRC and ABL tyrosine kinases |
€70.00 |
|
1698
|
A 770041
|
Orally active src-family selective lck inhibitor |
€140.00 |
|
1857
|
AP 24534
|
BCR-ABL kinase inhibitor (including T315I mutation) |
€70.00 |
|
1882
|
GNF 2
|
Inhibitor of Bcr-Abl tyrosine kinase |
€110.00 |
|
1941
|
MLR 1023
|
Selective allosteric activator of Lyn kinase |
€95.00 |
|
2097
|
CGP 77675
|
Src Family kinase (SFK) inhibitor |
€65.00 |
|
2121
|
INNO 406
|
Dual Bcr-Abl and Lyn kinase inhibitor |
€85.00 |
|
2123
|
DCC 2036
|
An orally active Bcr-ABL inhibitor |
€110.00 |
|
2219
|
AT 9283
|
Multitargeted kinase inhibitor (Aurora A/B, JAK2/3, and BCR-Abl) |
€85.00 |
|
1892
|
1-NM-PP1
|
Potent tyrosine kinase inhibitor (TKI) of multiple targets (Src, Fyn, Abl, CDK, Trk) |
€95.00 |
|
2366
|
NG 25 trihydrochloride
|
Type II inhibitor of TAK1 (MAP3K7) and MAP4K2 (GCK) |
€75.00 |
|
2381
|
WH-4-023
|
Orally active src-family selective lck inhibitor |
€90.00 |
|
2560
|
Tilfrinib
|
Brk inhibitor with antiproliferative activity in breast tumor cells |
€95.00 |
|
2778
|
Squarunkin A
|
Selective UNC119–cargo interaction inhibitor |
€125.00 |
|
3168
|
Nilotinib hydrochloride
|
BCR-ABL inhibitor |
€70.00 |
|
3284
|
Saracatinib
|
Inhibitor of SRC and ABL tyrosine kinases |
€70.00 |
|
3099
|
TL02-59
|
Potent, selective and orally active Fgr and Lyn inhibitor |
€120.00 |
|
2757
|
Asciminib
|
Potent and selective allosteric BCR-ABL1 inhibitor |
€120.00 |
|
3973
|
XL-228
|
Multitargeted protein kinase inhibitor (IGF1R, Aurora,FGFR, ABL,ALK and SRC) |
Inquire |
|
4010
|
BLK degrader compound 9
|
First potent and highly selective monomeric degrader of B-lymphoid tyrosine kinase (BLK) |
€180.00 |